Key result
Pulmonary artery sarcoma was associated with a poor prognosis, with 5 of 9 patients dying after a mean of 2.1 years, though long-term survival was possible with surgical resection.
Observational (n=9)
No
Pulmonary artery sarcoma is a rare, aggressive tumor often mimicking pulmonary embolism, but long-term survival is possible with early diagnosis and prompt surgical resection.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to sarcoma in atypical PE presentations; leaves open optimal surgical selection pending larger studies.
BACKGROUND: Pulmonary artery sarcoma (PAS) is a rare malignant neoplasm with an aggressive behavior and often difficult to distinguish from pulmonary thromboembolic disease. AIM: To assess the demographic, clinical, and radiological characteristics of PAS and clinical course. DESIGN AND METHODS: We retrospectively identified and analyzed all patients with PAS seen at Mayo Clinic in Rochester, Minnesota, between January 1, 1996 and July 31, 2015. RESULTS: Of nine patients (5 women and 4 men; median age 55 years [range, 24-74 years]), eight were diagnosed while alive with surgical ( n = 6) or catheter-based endovascular biopsy ( n = 2); the remaining patient was diagnosed at postmortem examination. All tumors manifested on CT as filling defect in the main, right or left pulmonary artery and were not associated with peripheral filling defects in seven patients. Seven patients were initially treated with anticoagulant therapy for presumed PE; two patients were suspected to have tumor based on constrictive or expanding effect seen on CT. Five patients died after a mean duration of 2.1 years (10 months-4.25 years) after diagnosis. Two patients are alive with recurrence and metastases of the disease 23 and 27 months after diagnosis, respectively; one remaining patient is alive and disease-free 116 months after diagnosis. CONCLUSIONS: Although PAS is associated with a poor prognosis, long-term survival is possible and can be improved by early diagnosis and prompt surgical resection. Atypical appearance on CT including central mass-like lesion without peripheral emboli and constrictive or expanding effect should raise suspicion of PAS.
No takes yet. Share an insight, caveat, or question.
Srivali et al. (2016) conducted an observational in Pulmonary artery sarcoma (PAS) (n=9). Pulmonary artery sarcoma was evaluated on Clinical course and survival. Pulmonary artery sarcoma was associated with a poor prognosis, with 5 of 9 patients dying after a mean of 2.1 years, though long-term survival was possible with surgical resection.
Synapse has enriched 10 related papers. Consider them for comparative context: